Ascentage Pharma Group International (6855.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 16.71B |
| Enterprise Value | 16.22B |
| P/E Ratio | -7.23 |
| PEG Ratio | 0.71 |
| Price/Sales Ratio | 16.53 |
| Price/Book Ratio | 18.87 |
| Enterprise/Revenue | 16.85 |
| Enterprise/EBITDA | -8.21 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.29 |
| Operating Margin | -2.19 |
AD
Management Effectiveness
| Return On Assets | -0.45 |
| Return On Equity | -1.54 |
Income Statement
| Revenue | 559.26M |
| Revenue/Share | 1.7 |
| Gross Profit | 427.35M |
| EBITDA | -1.1B |
| Net Income | -1.21B |
| Diluted EPS | -3.4 |
Balance Sheet
| Total Cash | 1.9B |
| Total Cash/Share | 5.08 |
| Total Debt | 2.09B |
| Total Debt/Equity | 3.76 |
| Current Ratio | 1.22 |
| Book Value Per Share | 1.52 |
Price History
| 52-Week Change | -63.57 |
| 52-Week High | 91.5 |
| 52-Week Low | 30 |
| Moving Average 50 Days | 34.82 |
| Moving Average 200 Days | 45.9 |
Statistics
| Average Volume | 2.71M |
| Shares Outstanding | 372.01M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
